JP2008514586A5 - - Google Patents

Download PDF

Info

Publication number
JP2008514586A5
JP2008514586A5 JP2007533055A JP2007533055A JP2008514586A5 JP 2008514586 A5 JP2008514586 A5 JP 2008514586A5 JP 2007533055 A JP2007533055 A JP 2007533055A JP 2007533055 A JP2007533055 A JP 2007533055A JP 2008514586 A5 JP2008514586 A5 JP 2008514586A5
Authority
JP
Japan
Prior art keywords
polymer
amino acid
residue
hydrophobic component
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007533055A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008514586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2005/001030 external-priority patent/WO2006035431A2/en
Publication of JP2008514586A publication Critical patent/JP2008514586A/ja
Publication of JP2008514586A5 publication Critical patent/JP2008514586A5/ja
Pending legal-status Critical Current

Links

JP2007533055A 2004-09-27 2005-09-26 新規な抗菌剤 Pending JP2008514586A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61277804P 2004-09-27 2004-09-27
PCT/IL2005/001030 WO2006035431A2 (en) 2004-09-27 2005-09-26 Fatty acid modified polylysines as antimicrobial agents

Publications (2)

Publication Number Publication Date
JP2008514586A JP2008514586A (ja) 2008-05-08
JP2008514586A5 true JP2008514586A5 (enExample) 2008-10-16

Family

ID=35930003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007533055A Pending JP2008514586A (ja) 2004-09-27 2005-09-26 新規な抗菌剤

Country Status (8)

Country Link
US (3) US7504381B2 (enExample)
EP (1) EP1793837A2 (enExample)
JP (1) JP2008514586A (enExample)
CN (1) CN101065131B (enExample)
AU (1) AU2005288519A1 (enExample)
CA (1) CA2581883A1 (enExample)
MX (1) MX2007003608A (enExample)
WO (1) WO2006035431A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060013862A1 (en) * 2004-07-19 2006-01-19 Held Jerry M Onychomycosis: a new process for cure
US7915223B2 (en) * 2004-09-27 2011-03-29 Technion Research & Development Foundation Ltd. Antimicrobial agents
SI2390255T1 (sl) * 2006-04-03 2016-12-30 Technion Research & Development Foundation Ltd. Novi aminoglikozidi in njihove uporabe pri zdravljenju genetskih motenj
AU2007250558B2 (en) * 2006-05-16 2012-10-25 Pergamum Ab Improved antimicrobial peptides
US8710179B2 (en) 2006-12-14 2014-04-29 Technion Research & Development Foundation Limited Compositions and methods for concentrating and depleting microorganisms
EP2118122B1 (en) * 2007-01-16 2015-09-23 The Regents of The University of California Novel antimicrobial peptides
US20080214417A1 (en) * 2007-02-07 2008-09-04 University Of Waterloo Lubricant for wear testing of joint replacements and associated materials
FR2913335B1 (fr) * 2007-03-06 2009-06-05 Michel Geffard Utilisation de conjugues d'acides gras et de poly-l-lysine pour lutter contre des microorganismes pathogenes.
EP2152289A1 (en) * 2007-04-30 2010-02-17 Technion Research & Development Foundation Ltd. Novel antimicrobial agents
WO2008132738A2 (en) 2007-04-30 2008-11-06 Technion Research & Development Foundation Ltd. Anticancerous polymeric agents
CA2730544C (en) 2008-07-11 2017-08-29 Universal Biosensors Pty Ltd Enhanced immunoassay sensor
JP2010154765A (ja) * 2008-12-26 2010-07-15 Hiroshi Kaino 健康食材
CZ301719B6 (cs) * 2009-02-12 2010-06-02 Ústav organické chemie a biochemie Akademie ved Ceské republiky, v. v. i. Antimikrobiální peptidy
JP2010279329A (ja) * 2009-06-08 2010-12-16 Hiroshi Kaino 健康食材
RU2400069C1 (ru) * 2009-06-11 2010-09-27 Галина Ивановна Эль-Регистан Способ защиты материалов от микробного разрушения
US8951563B2 (en) 2009-08-06 2015-02-10 Technion Research & Development Foundation Limited Antibiotic drug delivery and potentiation
US9264184B2 (en) * 2009-10-30 2016-02-16 Sony Corporation Coordinated signaling of scheduling information for uplink and downlink communications
EP2533828B1 (en) * 2010-02-09 2019-02-27 ExThera Medical Corporation Removal of virulence factors through extracorporeal therapy
WO2012081944A2 (en) * 2010-12-16 2012-06-21 Republic Of Korea(Management : Rural Development Administration) Dental membrane and method of manufacturing the same
US20120219682A1 (en) * 2011-02-28 2012-08-30 Frank Monteleone Antimicrobial compositions within antioxidant solutions used to protect whole protein foods
EP2779998A1 (en) 2011-11-16 2014-09-24 3M Innovative Properties Company Polymeric colorant compositions and methods of use
EP2991638B1 (en) * 2013-05-01 2019-06-26 Neoculi Pty Ltd Methods for treating bacterial infections
US20190255141A1 (en) * 2016-06-17 2019-08-22 Erasmus University Medical Center Rotterdam Geminoid lipopeptide compounds and their uses
CN112386563A (zh) * 2019-08-12 2021-02-23 湖南早晨纳米机器人有限公司 微纳米载药机器人及其制备方法
CN113563261B (zh) * 2021-07-28 2023-09-01 西北大学 一种水溶性多脲抗菌分子及其制备方法和应用
CN114533679B (zh) * 2022-01-28 2023-03-14 马超锋 一种磺胺氯哒嗪缓释纳米胶粒及其制备方法
CN119837867B (zh) * 2025-01-13 2025-10-03 中国水产科学研究院长江水产研究所 防耐药复方氟苯尼考与盐酸小檗碱粉剂的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
WO1995011921A1 (en) * 1993-10-25 1995-05-04 National Research Council Of Canada Bivalent thrombin inhibitors
US6057291A (en) * 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
WO1998018501A2 (en) * 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
US6571790B1 (en) * 1997-05-12 2003-06-03 Robert E. Weinstein Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders
US6548048B1 (en) * 1998-04-28 2003-04-15 Amersham Health As Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
HRP20010119B1 (hr) * 1998-08-18 2008-05-31 The Regents Of The University Of California Sprječavanje stvaranja sluzi u dišnim putevima primjenom antagonista egf-r
GB9928323D0 (en) * 1999-11-30 2000-01-26 Cyclacel Ltd Peptides
US6637430B1 (en) * 2000-06-16 2003-10-28 Ponwell Enterprises Limited Respiratory delivery system with power/medicament recharge assembly
FR2813080B1 (fr) * 2000-08-17 2002-11-29 Stago Diagnostica Peptides anti-heparine
WO2003035677A2 (en) * 2001-08-17 2003-05-01 University Of Bern Antimicrobial peptides from the venom of the spider cupiennius salei
US6652323B2 (en) * 2002-02-19 2003-11-25 Leon M. Yanda Precision parking device
JP2007512234A (ja) * 2003-10-17 2007-05-17 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 治療活性を有する修飾ポリペプチド及びその使用方法

Similar Documents

Publication Publication Date Title
JP2008514586A5 (enExample)
JP2008537537A5 (enExample)
RU2470016C2 (ru) Производное бипиразола
JP2013155195A5 (enExample)
JP2013500990A5 (enExample)
US8148328B2 (en) Salicylanilides enhance oral delivery of therapeutic peptides
US7671011B2 (en) Antimicrobial and anticancer lipopeptides
AU2010231136B2 (en) Inhibition of biofilm organisms
RU2590706C2 (ru) Пептиды и их применение
EP3000481A3 (en) Peptide-mediated non-covalent delivery of active agent agents across the blood brain barrier
JP2021100937A5 (enExample)
JP2010515686A5 (enExample)
IL256395A (en) Stabilized antimicrobial peptides
JP2010512753A5 (enExample)
US20110183889A1 (en) Salicylanilide modified peptides for use as oral therapeutics
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
JP2011511753A5 (enExample)
EP2465865A3 (en) Peptide vaccines for cancers expressing tumor-associated antigens
WO2008039483A3 (en) Modified self-assembling peptides
JP2005530732A5 (enExample)
JP2015128593A5 (enExample)
JP2013515057A5 (enExample)
JP2010513327A5 (enExample)
JPWO2022202816A5 (enExample)
JP2010502585A5 (enExample)